共 50 条
- [44] NAT1 genotypes do not predict response to mesalamine in patients with ulcerative colitis ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2008, 46 (03): : 259 - 265
- [45] A Review of Delayed-Release MMX Mesalamine: It's Use in the Treatment of Ulcerative Colitis CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 45 - 51
- [49] Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX (R) mesalamine CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2012, 4 : 41 - 50
- [50] Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn's disease CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2009, 2 : 139 - 147